Pages that link to "Q39990565"
Jump to navigation
Jump to search
The following pages link to Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system. (Q39990565):
Displaying 44 items.
- Recent progress in West Nile virus diagnosis and vaccination (Q21284433) (← links)
- Vaccines in development against West Nile virus (Q26999702) (← links)
- Identification of Mutated Cyclization Sequences That Permit Efficient Replication of West Nile Virus Genomes: Use in Safer Propagation of a Novel Vaccine Candidate (Q27486407) (← links)
- Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2 (Q27487946) (← links)
- Extension of Flavivirus Protein C Differentially Affects Early RNA Synthesis and Growth in Mammalian and Arthropod Host Cells (Q27490326) (← links)
- A trans-Complementing Recombination Trap Demonstrates a Low Propensity of Flaviviruses for Intermolecular Recombination (Q27490533) (← links)
- PCP Consensus Sequences of Flaviviruses: Correlating Variance with Vector Competence and Disease Phenotype (Q27490925) (← links)
- Efficient, trans-complementing packaging systems for chimeric, pseudoinfectious dengue 2/yellow fever viruses (Q27491035) (← links)
- Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection (Q33880730) (← links)
- Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis (Q34053031) (← links)
- Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus (Q34261441) (← links)
- Current trends in West Nile virus vaccine development (Q34788758) (← links)
- Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling. (Q35742553) (← links)
- Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model (Q35753613) (← links)
- Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection (Q35837150) (← links)
- Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis (Q36411126) (← links)
- TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate (Q37254256) (← links)
- West Nile virus genome with glycosylated envelope protein and deletion of alpha helices 1, 2, and 4 in the capsid protein is noninfectious and efficiently secretes subviral particles. (Q37336383) (← links)
- Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses (Q37350360) (← links)
- Construction and characterisation of a complete reverse genetics system of dengue virus type 3. (Q37734118) (← links)
- RNA replicons - a new approach for influenza virus immunoprophylaxis (Q37945198) (← links)
- RNA-based viral vectors (Q38266413) (← links)
- An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection (Q38866173) (← links)
- Analyses of mutations selected by passaging a chimeric flavivirus identify mutations that alter infectivity and reveal an interaction between the structural proteins and the nonstructural glycoprotein NS1. (Q39458024) (← links)
- A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector (Q40044973) (← links)
- Subcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responses (Q40218664) (← links)
- Construction of yellow fever virus subgenomic replicons by yeast-based homologous recombination cloning technique (Q40255532) (← links)
- Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate (Q40352155) (← links)
- Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations (Q40354696) (← links)
- RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters (Q40383859) (← links)
- Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis. (Q40420984) (← links)
- Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine (Q41218531) (← links)
- Ion channels in volume regulation of clonal kidney cells (Q42840259) (← links)
- Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity Cellufine Sulfate column (Q43035493) (← links)
- Characterization of the RepliVax platform for replication-defective flavivirus vaccines (Q43037233) (← links)
- Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene (Q43039120) (← links)
- Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing (Q45375753) (← links)
- Nucleic Acid-Based Infectious and Pseudo-Infectious Flavivirus Vaccines (Q56795718) (← links)
- A Single-Dose Live-Attenuated Zika Virus Vaccine with Controlled Infection Rounds that Protects against Vertical Transmission (Q57283094) (← links)
- Lymph nodes as barriers to T-cell rejuvenation in aging mice and nonhuman primates (Q59350941) (← links)
- Vaccination with a Single-Cycle Respiratory Syncytial Virus Is Immunogenic and Protective in Mice (Q90024491) (← links)
- An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults (Q91129614) (← links)
- Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector (Q92288781) (← links)
- The role of capsid in the flaviviral life cycle and perspectives for vaccine development (Q99575005) (← links)